Table 4 Time varying cox analysis of hypertension stages for major adverse cardiovascular events according to both age and sex groups.
Group | 40–49 | 50–59 | 60–69 | 70+ | ||||
|---|---|---|---|---|---|---|---|---|
HR | 95% CI | HR | 95% CI | HR | 95% CI | HR | 95% CI | |
Male | ||||||||
Normal BP | Reference | Reference | Reference | Reference | ||||
Elevate BP | 1.13 | (0.93–1.38) | 1.02 | (0.82–1.28) | 1.02 | (0.79–1.3) | 0.68 | (0.42–1.11) |
Stage 1 HTN | 1.30 | (1.14–1.48) | 1.11 | (0.95–1.29) | 1.19 | (1.00–1.41) | 1.00 | (0.74–1.34) |
Stage 2 HTN | 1.97 | (1.70–2.29) | 1.74 | (1.48–2.05) | 1.39 | (1.15–1.66) | 1.50 | (1.12–2.00) |
Female | ||||||||
Normal BP | Reference | Reference | Reference | Reference | ||||
Elevate BP | 1.09 | (0.79–1.49) | 1.30 | (0.98–1.73) | 0.98 | (0.71–1.35) | 1.14 | (0.70–1.87) |
Stage 1 HTN | 1.20 | (0.96–1.50) | 1.21 | (0.98–1.51) | 1.37 | (1.10–1.71) | 1.54 | (1.10–2.16) |
Stage 2 HTN | 1.59 | (1.18–2.15) | 1.25 | (0.95–1.64) | 1.65 | (1.31–2.09) | 1.63 | (1.16–2.31) |